Reproductive history and breast cancer prevention

References

1. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718–29.10.1016/S0959-8049(03)00118-7Search in Google Scholar

2. Clarke CA, Purdie DM, Glaser SL. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer 2006;6:170–81.10.1186/1471-2407-6-170Search in Google Scholar PubMed PubMed Central

3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.10.3322/caac.20107Search in Google Scholar PubMed

4. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 2005;34:405–12.10.1093/ije/dyh414Search in Google Scholar PubMed

5. Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT. Ethnic and geographic differences in mammographic density and their association with breast cancer incidence. Breast Cancer Res Treat 2007;104:47–56.10.1007/s10549-006-9387-5Search in Google Scholar PubMed

6. Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006;36:387–94.10.1093/jjco/hyl031Search in Google Scholar PubMed

7. Hinkula M, Pukkala E, Kyyronen P, Kauppila A. Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 2001;12:491–500.10.1023/A:1011253527605Search in Google Scholar

8. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S. Age at first birth and breast cancer risk. Bull World Health Organ 1970;43:209–21.Search in Google Scholar

9. Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross PL, Largent J, Deapen DM, Lacey JV Jr, Bernstein L. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 2010;12:R35.10.1186/bcr2589Search in Google Scholar PubMed PubMed Central

10. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011;103:470–7.10.1093/jnci/djr030Search in Google Scholar PubMed PubMed Central

11. Toniolo P, Grankvist K, Wulff M, Chen T, Johansson R, Schock H, Lenner P, Hallmans G, Lehtinen M, Kaaks R, Wadell G, Zeleniuch-Jacquotte A, Lundin E, Lukanova A, Schock H, Lenner P, Hallmans G, Lehtinen M, Kaaks R, Wadell G, Zeleniuch-Jacquotte A, Lundin E, Lukanova A. Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer. Cancer Res 2010;70:6779–86.10.1158/0008-5472.CAN-09-4622Search in Google Scholar PubMed PubMed Central

12. Mustacchi P. Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch Intern Med 1961;108:639–42.10.1001/archinte.1961.03620100131018Search in Google Scholar

13. Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 2008;100:1643–8.10.1093/jnci/djn344Search in Google Scholar

14. Kroman N, Melbye M, Mouridsen HT. Prognostic influence of age at diagnosis in premenopausal breast cancer patients. Scand J Surg 2002;91:305–8.10.1177/145749690209100315Search in Google Scholar

15. Kroman N, Mouridsen HT. Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast 2003;12:516–21.10.1016/S0960-9776(03)00159-0Search in Google Scholar

16. Downs JL, Wise PM. The role of the brain in female reproductive aging. Mol Cell Endocrinol 2009;299:32–8.10.1016/j.mce.2008.11.012Search in Google Scholar

17. Russo IH, Medado J, Russo J. Endocrine influences on mammary gland structure and development. In: Jones TC, Mohr U, Hunt RD, editors. Integument and mammary gland of laboratory animals. Berlin: Springer Verlag, 1989:252–66.10.1007/978-3-642-83749-4_39Search in Google Scholar

18. Chen T, Lundin E, Grankvist K, Zeleniuch-Jacquotte A, Wulff M, Lenner P, Hallmans G, Wadell G, Toniolo P, Lukanova A. Maternal hormones during early pregnancy: a cross-sectional study. Cancer Causes Control 2010;21:719–27.10.1007/s10552-009-9500-2Search in Google Scholar

19. Albrektsen G, Heuch I, Thoresen S, Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev 2006;15:65–9.10.1158/1055-9965.EPI-05-0634Search in Google Scholar

20. Beatson G. On the treatment of inoperable cases of carcinoma of the mammary. Suggestions for new method of treatment with illustrative cases. Lancet 1896;2:104–7.10.1016/S0140-6736(01)72307-0Search in Google Scholar

21. Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Husing A, Kaaks R, Koskela P, Grankvist K, Pukkala E, Zeleniuch-Jacquotte A, Lehtinen M, Toniolo P. Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Intl J Cancer 2011;130:910–20.10.1002/ijc.26070Search in Google Scholar PubMed PubMed Central

22. Russo J, Russo IH, editors. Molecular basis of breast cancer: prevention and treatment. Berlin: Springer-Verlag, 2004:447.10.1007/978-3-642-18736-0Search in Google Scholar

23. Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006;102:89–96.10.1016/j.jsbmb.2006.09.004Search in Google Scholar PubMed PubMed Central

24. Blackshaw S, Scholpp S, Placzek M, Ingraham H, Simerly R, Shimogori T. Molecular pathways controlling development of thalamus and hypothalamus: from neural specification to circuit formation. J Neurosci 2010;30:14925–30.10.1523/JNEUROSCI.4499-10.2010Search in Google Scholar PubMed PubMed Central

25. Hendriks AE, Laven JS, Valkenburg O, Fong SL, Fauser BC, de Ridder MA, de Jong FH, Visser JA, van Ginneken AM, Boot AM, Drop SL. Fertility and ovarian function in high-dose estrogen-treated tall women. J Clin Endocrinol Metab 2011;96:1098–105.10.1210/jc.2010-2244Search in Google Scholar PubMed

26. Russo J, Russo IH. Development of the human mammary gland. In: Neville MC, Daniel C, editors. The mammary gland. New York: Plenum, 1987:67–93.10.1007/978-1-4899-5043-7_3Search in Google Scholar

27. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992;23:211–8.10.1007/BF01833517Search in Google Scholar PubMed

28. Russo J, Santucci-Pereira J, de Cicco RL, Sheriff F, Russo PA, Peri S, Slifker M, Ross E, Mello ML, Vidal BC, Belitskaya-Lévy I, Arslan A, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Ahman J, Afanasyeva Y, Hallmans G, Toniolo P, Russo IH. Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. Int J Cancer 2012;131:1059–70.10.1002/ijc.27323Search in Google Scholar PubMed PubMed Central

29. Harvey JA, Santen RJ, Petroni GR, Bovbjerg VE, Smolkin ME, Sheriff FS, Russo J. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 2008;15:67–73.10.1097/gme.0b013e318054e29aSearch in Google Scholar PubMed PubMed Central

30. Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F. The Women’s Health Initiative trial and related studies: 10 years later: a clinician’s view. J Steroid Biochem Mol Biol 2014;142:4–11.10.1016/j.jsbmb.2013.10.009Search in Google Scholar PubMed

31. Ghazal S, Pal L. Perspective on hormone therapy 10 years after the WHI. Maturitas 2013;76:208–12.10.1016/j.maturitas.2013.08.014Search in Google Scholar PubMed

32. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O’Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. J Am Med Assoc 2013;310:1353–68.10.1001/jama.2013.278040Search in Google Scholar PubMed PubMed Central

33. Obiorah I, Jordan VC. Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality. Menopause 2013;20:372–82.10.1097/GME.0b013e31828865a5Search in Google Scholar PubMed PubMed Central

34. Santen RJ. Menopausal hormone therapy and breast cancer. J Steroid Biochem Mol Biol 2014;142:52–61.10.1016/j.jsbmb.2013.06.010Search in Google Scholar PubMed

35. Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL, WHI Investigators. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304:1684–92.10.1001/jama.2010.1500Search in Google Scholar PubMed PubMed Central

36. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G, WHI Investigators. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2009;360:573–87.10.1056/NEJMoa0807684Search in Google Scholar PubMed PubMed Central

37. Lathi RB. Implantation and placental physiology in early human pregnancy: the role of the maternal decidua and the trophoblast. In: De Groot L, Jameson LJ, editors. Endocrinology. Philadelphia: Elsevier Saunders, 2006:3341–51.Search in Google Scholar

38. Parry S, Strauss F. Placental hormones. In: De Groot L, Jameson L, editors. Endocrinology. Philadelphia: Elsevier Saunders, 2006:3353–67.Search in Google Scholar

39. Alvarado M, Ho T-Y, Russo J, Russo I. Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and the mammary gland of rats. Endocrine 1994;2:1107–14.Search in Google Scholar

40. Alvarado MV, Alvarado NE, Russo J, Russo IH. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human breast epithelial cells in vitro. In Vitro Cell Dev Biol Anim 1994;30A:4–8.10.1007/BF02631407Search in Google Scholar PubMed

41. Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, Fujino M. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 2003;88:914–9.10.1210/jc.2002-021235Search in Google Scholar PubMed

42. Russo IH, Koszalka M, Russo J. Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 1991;64:481–4.10.1038/bjc.1991.335Search in Google Scholar PubMed PubMed Central

43. Russo J, Russo IH. Role of differentiation in the pathogenesis and prevention of breast cancer. Endocr Relat Cancer 1997;4:7–21.10.1677/erc.0.0040007Search in Google Scholar

44. Russo J, Balogh GA, Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 2008;17:51–66.10.1158/1055-9965.EPI-07-0678Search in Google Scholar PubMed

45. Russo IH, Russo J. Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia 2011;16:221–33.10.1007/s10911-011-9228-ySearch in Google Scholar PubMed

46. Belitskaya-Levy I, Zeleniuch-Jacquotte A, Russo J, Russo IH, Bordas P, Ahman J, Afanasyeva Y, Johansson R, Lenner P, Li X, de Cicco RL, Peri S, Ross E, Russo PA, Santucci-Pereira J, Sheriff FS, Slifker M, Hallmans G, Toniolo P, Arslan AA. Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res 2011;4:1457–64.10.1158/1940-6207.CAPR-11-0021Search in Google Scholar PubMed PubMed Central

47. Peri S, de Cicco RL, Santucci-Pereira J, Slifker M, Ross EA, Russo IH, Russo PA, Arslan AA, Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Åhman J, Afanasyeva Y, Johansson R, Sheriff F, Hallmans G, Toniolo P, Russo J. Defining the genomic signature of the parous breast. BMC Med Genomics 2012;5:46–57.10.1186/1755-8794-5-46Search in Google Scholar PubMed PubMed Central

48. Golob JL, Paige SL, Muskheli V, Pabon L, Murry CE. Chromatin remodeling during mouse and human embryonic stem cell differentiation. Dev Dyn 2008;237:1389–98.10.1002/dvdy.21545Search in Google Scholar PubMed PubMed Central

49. Asztalos S, Gann PH, Hayes MK, Nonn L, Beam CA, Dai Y, Wiley EL, Tonetti DA. Gene expression patterns in the human breast after pregnancy. Cancer Prev Res 2010;3:301–11.10.1158/1940-6207.CAPR-09-0069Search in Google Scholar PubMed

50. Wilson BJ, Giguere V. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer 2008;7:49–57.10.1186/1476-4598-7-49Search in Google Scholar PubMed PubMed Central

51. Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol 2010;222:42–9.10.1002/jcp.21943Search in Google Scholar PubMed PubMed Central

52. D’Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA, Chodosh LA. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 2002;16:2034–51.10.1210/me.2002-0073Search in Google Scholar PubMed

53. Medina D. Breast cancer: the protective effect of pregnancy. Clin Cancer Res 2004;10:380S–4S.10.1158/1078-0432.CCR-031211Search in Google Scholar

54. Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 1996;104:938–67.10.1289/ehp.96104938Search in Google Scholar PubMed PubMed Central

55. Russo J, Tait L, Russo IH. Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am J Pathol 1983;113:50–66.Search in Google Scholar

56. Erwin JA, Lee JT. Characterization of X-chromosome inactivation status in human pluripotent stem cells. Curr Protoc Stem Cell Biol 2010;Chapter 1:Unit 1B 6.10.1002/9780470151808.sc01b06s12Search in Google Scholar PubMed PubMed Central

57. Huang PR, Hung SC, Wang TC. Telomeric DNA-binding activities of heterogeneous nuclear ribonucleoprotein A3 in vitro and in vivo. Biochim Biophys Acta 2010;1803:1164–74.10.1016/j.bbamcr.2010.06.003Search in Google Scholar PubMed

58. Bussolati G, Marchio C, Gaetano L, Lupo R, Sapino A. Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem. J Cell Mol Med 2008;12:209–18.10.1111/j.1582-4934.2007.00176.xSearch in Google Scholar PubMed PubMed Central

59. Palmer JE, Sant Cassia LJ, Irwin CJ, Morris AG, Rollason TP. The prognostic value of nuclear morphometric analysis in serous ovarian carcinoma. Intl J Gynecol Cancer 2008;18:692–701.10.1111/j.1525-1438.2007.01093.xSearch in Google Scholar PubMed

60. Tan PH, Goh BB, Chiang G, Bay BH. Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast. Mod Pathol 2001;14:937–41.10.1038/modpathol.3880415Search in Google Scholar PubMed

61. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002;298:1039–43.10.1126/science.1076997Search in Google Scholar PubMed

62. Kubicek S, Schotta G, Lachner M, Sengupta R, Kohlmaier A, Perez-Burgos L, Linderson Y, Martens JH, O’Sullivan RJ, Fodor BD, Yonezawa M, Peters AH, Jenuwein T. The role of histone modifications in epigenetic transitions during normal and perturbed development. Ernst Schering Res Fdn Workshop 2006;57:1–27.10.1007/3-540-37633-X_1Search in Google Scholar PubMed

63. Lin W, Dent SY. Functions of histone-modifying enzymes in development. Curr Opin Genet Dev 2006;16:137–42.10.1016/j.gde.2006.02.002Search in Google Scholar PubMed

64. Guenther MG, Young RA. Transcription. Repressive transcription. Science 2010;329:150–1.10.1126/science.1193995Search in Google Scholar PubMed PubMed Central

65. Han SP, Friend LR, Carson JH, Korza G, Barbarese E, Maggipinto M, Hatfield JT, Rothnagel JA, Smith R. Differential subcellular distributions and trafficking functions of hnRNP A2/B1 spliceoforms. Traffic 2010;11:886–98.10.1111/j.1600-0854.2010.01072.xSearch in Google Scholar PubMed PubMed Central

66. Loyer P, Trembley JH, Grenet JA, Busson A, Corlu A, Zhao W, Kocak M, Kidd VJ, Lahti JM. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. J Biol Chem 2008;283:7721–32.10.1074/jbc.M708188200Search in Google Scholar PubMed

67. Yang L, Li N, Wang C, Yu Y, Yuan L, Zhang M, Cao X. Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells. J Biol Chem 2004;279:11639–48.10.1074/jbc.M312895200Search in Google Scholar PubMed

68. Fushimi K, Ray P, Kar A, Wang L, Sutherland LC, Wu JY. Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl Acad Sci USA 2008;105:15708–13.10.1073/pnas.0805569105Search in Google Scholar PubMed PubMed Central

69. Kobayashi T, Ishida J, Musashi M, Ota S, Yoshida T, Shimizu Y, Chuma M, Kawakami H, Asaka M, Tanaka J, Imamura M, Kobayashi M, Itoh H, Edamatsu H, Sutherland LC, Brachmann RK. p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5. Intl J Cancer 2011;128:304–18.10.1002/ijc.25345Search in Google Scholar PubMed

70. Salomonis N, Schlieve CR, Pereira L, Wahlquist C, Colas A, Zambon AC, Vranizan K, Spindler MJ, Pico AR, Cline MS, Clark TA, Williams A, Blume JE, Samal E, Mercola M, Merrill BJ, Conklin BR. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc Natl Acad Sci USA 2010;107:10514–9.10.1073/pnas.0912260107Search in Google Scholar PubMed PubMed Central

71. Santucci-Pereira J, Zeleniuch-Jacquotte A, Afanasyeva Y, Zhong H, Peri S. Gene expression profile induced by pregnancy in the breast of premenopausal women. In: American Association for Cancer Research Annual Meeting 2014. New York, 2014:2360A.10.1158/1538-7445.AM2014-2360Search in Google Scholar